Phase 2 study of efgartigimod, a novel FcRn antagonist, in adult patients with primary immune thrombocytopenia-Reference-Cited by-同舟云学术

Phase 2 study of efgartigimod, a novel FcRn antagonist, in adult patients with primary immune thrombocytopenia

Published:2019-12-10 Issue:2 Volume:95 Page:178-187
ISSN:0361-8609
Container-title:American Journal of Hematology
language:en
Short-container-title:Am J Hematol

Author:

Newland Adrian C.¹,Sánchez‐González Blanca²,Rejtő László³,Egyed Miklos⁴,Romanyuk Nataliya⁵,Godar Marie⁶^ORCID,Verschueren Katrien⁶,Gandini Domenica⁶,Ulrichts Peter⁶,Beauchamp Jon⁶,Dreier Torsten⁶,Ward E. Sally⁷⁸^ORCID,Michel Marc⁹,Liebman Howard A.¹⁰,Haard Hans⁶^ORCID,Leupin Nicolas⁶,Kuter David J.¹¹^ORCID

Affiliation:

1. Department of Haematology, Centre for HaematologyThe Royal London Hospital London UK

2. Department of HematologyHospital del Mar Barcelona Spain

3. Department of HematologyJósa András Teaching Hospital Nyíregyháza Hungary

4. Department of HematologyKaposi Mor Teaching Hospital Kaposvar Hungary

5. Mykolaiv Regional Clinical Hospital Mykolaiv Ukraine

6. argenx BVBAIndustriepark‐Zwijnaarde 7 Zwijnaarde Belgium

7. Department of Molecular and Cellular MedicineTexas A&M University Health Science Center College Station Texas

8. Centre for Cancer ImmunologyUniversity of Southampton Southampton UK

9. Service de Médecine Interne, Centre National de Référence des Cytopénies Auto‐Immunes de l'AdulteCentre Hospitalier Universitaire Henri‐Mondor, Assistance Publique‐Hôpitaux de Paris, Université Paris Est Créteil Créteil France

10. Jane Anne Nohl Division of Hematology, Department of MedicineUniversity of Southern California Los Angeles California

11. Department of HematologyMassachusetts General Hospital and Harvard Medical School Boston Massachusetts

Publisher

Wiley

Subject

Hematology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/ajh.25680

Reference45 articles.

1. Standardization of terminology, definitions and outcome criteria in immune thrombocytopenic purpura of adults and children: report from an international working group

2. Immune Thrombocytopenia

3. The American Society of Hematology 2011 evidence-based practice guideline for immune thrombocytopenia